Browning, R. L., Byrd, W. H., Gupta, N., Jones, J., Mo, X., Hertlein, E., . . . Byrd, J. C. (2016). Lenalidomide induces interleukin-21 production by T cells and enhances IL21-mediated cytotoxicity in chronic lymphocytic leukemia B cells. Cancer Immunol Res.
Citación estilo ChicagoBrowning, Rebekah L., William H. Byrd, Nikhil Gupta, Jeffrey Jones, Xiaokui Mo, Erin Hertlein, Lianbo Yu, Natarajan Muthusamy, y John C. Byrd. "Lenalidomide Induces Interleukin-21 Production By T Cells and Enhances IL21-mediated Cytotoxicity in Chronic Lymphocytic Leukemia B Cells." Cancer Immunol Res 2016.
Cita MLABrowning, Rebekah L., et al. "Lenalidomide Induces Interleukin-21 Production By T Cells and Enhances IL21-mediated Cytotoxicity in Chronic Lymphocytic Leukemia B Cells." Cancer Immunol Res 2016.